Extramedullary multiple myeloma (Q38064911)

28 August 2017

1 reference

title

Extramedullary multiple myeloma. (English)

1 reference

28 August 2017

2

Irene M Ghobrial

1 reference

28 August 2017

Matthew Weinstock

1

1 reference

28 August 2017

31 December 2012

1 reference

28 August 2017

1 reference

28 August 2017

54

1 reference

28 August 2017

6

1 reference

28 August 2017

1135-1141

1 reference

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

28 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Extraskeletal spread in multiple plasma cell myeloma:A review of 57 autopsied cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Extramedullary disease and targeted therapies for hematological malignancies--is the association real?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Bortezomib: an effective agent in extramedullary disease in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Multiple myeloma with extramedullary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.740562

10.3109/10428194.2012.740562

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23210572